Scope
Clear description of areas to be tested, sample counts, and any exclusions to avoid ambiguity in deliverables and pricing.
A well-prepared proposal sets expectations, reduces scope disputes, and documents compliance requirements for hazardous-material testing in clinical settings. It clarifies liability, sampling standards, and reporting format so decision-makers can evaluate cost, schedule, and regulatory risk with comparable bids.
Each reviewer contributes different approvals and documentation to move a proposal from draft to contract-ready.
The principal signs to certify the sampling plan and laboratory accreditation. This signatory confirms adherence to recognized standards and accepts technical responsibility for results and chain-of-custody procedures on behalf of the testing firm.
The facilities director signs to authorize access, accept the scope and schedule, and confirm site-specific controls. This signer accepts operational obligations such as space preparation, occupant notifications, and payment terms.
Clear description of areas to be tested, sample counts, and any exclusions to avoid ambiguity in deliverables and pricing.
Detail proposed sample types, locations, collection methods, and chain-of-custody procedures aligned with EPA, OSHA, or state guidance.
Name of accredited laboratory, testing methods (e.g., PLM, TEM for asbestos; EPA 3050B/7420 for lead), and expected turnaround times.
Infection-control, PPE, and containment measures specific to healthcare environments and transient patient populations.
Detailed timeline for mobilization, sampling, lab analysis, report delivery, and any contingency windows for delays.
Line-item pricing for sampling, laboratory analysis, travel, report preparation, and optional post-testing consulting or remediation oversight.
| Field | Configuration |
|---|---|
| Proposal Title Field | Required, single-line text |
| Sampling Table | Repeatable rows with sample type and count |
| Signature Field | Electronic signature with signer name and date |
| Routing Rule | Send to facilities, then procurement |
Ensure the chosen solution can produce signed PDFs, capture signer metadata, and provide secure storage compliant with facility policies.
30–90 days depending on pricing and material availability
2–7 business days after authorization
Usually 1–3 days on-site for medium facilities
3–10 business days depending on method
Within 48 hours of receiving lab results
Contract signed and access approved
Areas prepared and occupants notified
Samples collected per plan and sealed
Accredited lab performs analysis
Optica needed multi-site testing across three clinics to support renovation plans.
A clinic required strict chain-of-custody for sensitive facility samples.